Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events. - Schwarz, Carsten; Sutharsan, Sivagurunathan; Epaud, Ralph; Klingsberg, Ross C.; Fischer, Rainald; Rowe, Steven M.; Audhya, Paul K.; Ahluwalia, Neil; You, Xiaojun; Ferro, Thomas J.; Duncan, Margaret E.; Bruinsma, Bote G. (Journal of Cystic Fibrosis, 2021)